Machine Learning

From automated bookings to data-driven operations, a new tech tide is rising, promising greater efficiency for operators and better experiences for boaters.

A new liquid biopsy more accurately predicts cancer recurrence than standard methods, offering new hope and clarity for patients after surgery.

Ensem Therapeutics expands its global trial for ETX-636, a next-gen cancer drug designed to avoid common toxicities, into China's vast patient market.

Following a federal probe into a Waymo robotaxi hitting a child, the Teamsters union calls for an indefinite ban, escalating the battle over AV safety and jobs.

Smashing its target, Hamilton Lane's new fund highlights intense investor appetite for assets powering AI, logistics, and the energy transition.

Forrester recognizes Kaltura for its AI, signaling a market shift toward hyper-personalized events, immersive avatars, and long-term content value.

Mwyngil Therapeutics starts clinical trials for a novel brain-penetrating drug, aiming to tackle neuroinflammation at its source in MS and Parkinson's.

A new report reveals banks are past debating AI, focusing instead on responsible deployment for fraud and efficiency, signaling a pragmatic future.

Izzi Software launches its Z/XDC debugger on VS Code, a strategic move to modernize legacy systems and solve the critical mainframe skills gap.

Brainomix launches its award-winning stroke AI platform with novel Net Water Uptake tech, promising to improve diagnoses, treatment decisions, and patient outcomes.

Opera Limited expects to smash Q4 revenue and profit forecasts, crediting its AI-driven strategy and a surge in its high-revenue Western user base.

Hyperscale Data reaffirms its $100M Bitcoin plan to fund its AI data center, defying a 95% stock drop and major financial red flags. Is it genius or folly?

HearingLife's new Oticon Zeal uses a brain-inspired AI to deliver crystal-clear sound in an invisible design, changing how we treat hearing loss.

VASVIK's 51st awards celebrate India's top scientists, blending service, global recognition, and cutting-edge industrial research for national growth.

Early clinical results for MP0712, a novel Radio-DARPin, suggest a breakthrough for targeting aggressive cancers like SCLC while sparing healthy tissue.

With an extra $3M, Aduro Clean Technologies advances its game-changing plant, turning investor confidence into a reality for recycling and energy.

NurExone appoints Eyal Gabbai, a healthcare and finance heavyweight, to its board, signaling a strategic pivot from R&D to market execution for its therapies.

Tevogen Bio's stock surged on news of a potential special dividend, but a closer look reveals a risky promise from a pre-revenue firm facing major hurdles.

NRG Energy doubles its power generation fleet in a massive $2.5 billion deal, betting on natural gas and virtual power plants to meet soaring demand.

Family-owned contractors are shifting from 'rented' leads to 'owned' digital assets, using Local SEO to gain control, predictability, and long-term stability.